Impact of Reported Beta-Lactam Allergy on Inpatient Outcomes: A Multicenter Prospective Cohort Study

Clinical Infectious Diseases

Volumn 63, Issue 7, 2016, Pages 904-910

  Macfadden, Derek R ^a   Ladelfa, Anthony ^b   Leen, Jessica ^b   Gold, Wayne L ^a   Daneman, Nick ^a   Weber, Elizabeth ^d   Al Busaidi, Ibrahim ^a   Petrescu, Dan ^a   Saltzman, Ilana ^a   Devlin, Megan ^a   Andany, Nisha ^a   Leis, Jerome A ^a,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b Department of Medicine ^*  (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

antimicrobial stewardship; beta lactam allergy; clinical outcome; penicillin allergy; quality improvement

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAM; CARBAPENEM; CEFTRIAXONE; CEPHALOSPORIN; CLINDAMYCIN; GLYCOPEPTIDE; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; VANCOMYCIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL OUTCOME; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONSULTATION; DRUG HYPERSENSITIVITY; FEBRILE NEUTROPENIA; FEMALE; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; ANTIMICROBIAL STEWARDSHIP; CLINICAL TRIAL; HOSPITALIZATION; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIMICROBIAL STEWARDSHIP; BETA-LACTAMS; DRUG HYPERSENSITIVITY; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84990909837     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciw462     Document Type: Article

References (25)

1. Blanca M, Torres MJ, Garcia JJ, et al. Natural evolution of skin test sensitivity in patients allergic to beta-lactam antibiotics. J Allergy Clin Immunol 1999; 103:918-24.
2. Solensky R, Khan D. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol 2010; 105:259-73.
3. McDanel J, Perencevich E, Diekema D, et al. Comparative effectiveness of betalactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals. Clin Infect Dis 2015; 61: 361-7.
4. Charneski L, Deshpande G, Smith S, et al. Impact of an antibiotic allergy label in the medical record on clinical outcomes in hospitalized patients. Pharmacotherapy 2011; 31:742-7.
5. Macy E, Contreras R. Healthcare use and serious infection prevalence associated with penicillin "allergy" in hospitalized patients: a cohort study. J Allergy Clin Immunol 2014; 133:790-6.
6. Mandell L, Wunderink R, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44:S27-72.
7. Tunkel A, Hartman B, Kaplan S, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39:1267-84.
8. Solomkin J, Mazuski J, Bradley J, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010; 50:133-64.
9. Stevens D, Bisno A, Chambers H, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 2014; 1:1-43.
10. Dellit T, Owens R, McGowan J, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antibiotic stewardship. Clin Infect Dis 2007; 44:159-77.
11. Wong BM, Goguen J, Shojania KG. Building capacity for quality: a pilot colearning curriculum in quality improvement for faculty and resident learners. J Grad Med Educ 2013; 5:689-93.
12. Charlson M, Pompei P, Ales K, MacKenzie C. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-83.
13. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs-The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8:R204-12.
14. Picard M, Begin P, Bouchard H, et al. Treatment of patients with a history of penicillin allergy in a large tertiary-care academic hospital. J Allergy Clin Immunol 2013; 1:252-7.
15. Shehab N, Patel PR, Srinivasan A, Budnitz DS. Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis 2008; 47:735-43.
16. Gex-collet C, Helbling A, Pichler W. Multiple drug hypersensitivity-proof of multiple drug hypersensitivity by patch and lymphocyte transformation tests. J Invest Allergol Clin Immunol 2005; 15:293-6.
17. Owens R, Curtis D, Gaynes R, et al. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 2008; 46:S19-31.
18. ChoosingWisely Canada: AMMI Canada Recommendations. Association of Medical Microbiology and Infectious Disease Canada. Available at: http://www. choosingwiselycanada.org/wp-content/uploads/2015/09/Medical-microbiologyand-Infectious-Disease.pdf. Accessed 29 April 2016.
19. Is It Really a Penicillin Allergy? Centers for Disease Control. Available at: http:// www.cdc.gov/getsmart/week/downloads/getsmart-penicillin-factsheet.pdf. Accessed 29 April 2016.
20. Blumenthal K, Shenoy E, Varughese C, et al. Impact of a clinical guidelines for prescribing antibiotics to inpatients reporting penicillin or cephalosporin allergy. Ann Allergy Asthma Immunol 2015; 115:294-300.
21. Unger N, Gauthier T, Cheung L. Penicillin skin testing: potential implications for antibiotic stewardship. Pharmacotherapy 2013; 33:856-67.
22. Blumenthal K, Parker RA, Shenoy ES, Walensky RP. Improving clinical outcomes in patients with methicillin-sensitive Staphylococcus aureus bacteremia and reported penicillin allergy. Clin Infect Dis 2015; 61:741-9.
23. Jeffrey J. Quality improvement in resident education: a pilot project to mitigate metabolic side effects from atypical antipsychotic medications in youth. BMJ Qual Improv Report 2015; doi:10.1136/bmjquality.u208804.w3544.
24. NICE. Drug allergy: diagnosis and management of drug allergy in adults children and young people. Clinical Guideline 183. NICE, 2014. Available at: www.nice.org. uk/guidance/CG183.
25. Trubiano J, Cairns K, Evans J, et al. The prevalence and impact of antimicrobial allergies and adverse drug reactions at an Australian tertiary centre. BMC Infect Dis 2015; 15:572.